Michaela Hall

1.1k citations

16 papers · 670 indexed · 1 hit paper · h-index 11

Impact in

Epidemiology top 5%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
Microbiology top 5%
- Reproductive tract infections research

Papers in ⓘ

Epidemiology 14
- Cervical Cancer and HPV Research 13
- Hepatitis B Virus Studies 3
Surgery 6
- Genital Health and Disease 6

Co-authors: Megan A. Smith (13 shared papers)Karen Canfell (14 shared papers)Kate T. Simms (9 shared papers)Jie‐Bin Lew (9 shared papers)Marion Saville (6 shared papers)Julia Brotherton (2 shared papers)Ian H. Frazer (1 shared paper)Ian Hammond (2 shared papers)
Journals: PLoS ONE (3 papers)Vaccine (2 papers)The Lancet Public Health (2 papers)Preventive Medicine (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
Partner nations: Australia United States Netherlands

In The Last Decade

Michaela Hall

15 papers receiving 659 citations

Hit Papers

align trajectories log scale

The projected timeframe until cervical cancer elimination in Australia: a modelling study 2018 · 301 citations

Peers

Countries citing papers authored by Michaela Hall

Since Specialization

Citations

This map shows the geographic impact of Michaela Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Hall more than expected).

Fields of papers citing papers by Michaela Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Hall. The network helps show where Michaela Hall may publish in the future.

Co-authors

The 25 scholars most cited alongside Michaela Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michaela Hall Line = papers co-authored together Michaela Hall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	The projected timeframe until cervical cancer elimination in Australia: a modelling study The Lancet Public Health ·Michaela Hall, Kate T. Simms, Jie‐Bin Lew, Megan A. Smith, Julia Brotherton, Marion Saville, Ian H. Frazer, Karen Canfell Hit paper breakdown →	2018	301
2	Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program The Lancet Public Health ·Jie‐Bin Lew, Kate T. Simms, Megan A. Smith, Michaela Hall, Yoon‐Jung Kang, Xiang Xu, Michael Caruana, Louiza S. Velentzis, Tracey Bessell, Marion Saville, Ian Hammond, Karen Canfell	2017	119
3	Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia PLoS ONE ·Michaela Hall, Kate T. Simms, Jie‐Bin Lew, Megan A. Smith, Marion Saville, Karen Canfell	2018	48
4	Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use BMC Health Services Research ·Megan A. Smith, Dorota M. Gertig, Michaela Hall, Kate T. Simms, Jie‐Bin Lew, Michael J. Malloy, Marion Saville, Karen Canfell	2016	37
5	Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis Preventive Medicine ·Megan A. Smith, Emily A. Burger, Alejandra Castañón, Inge M.C.M. de Kok, Sharon J. B. Hanley, Matejka Rebolj, Michaela Hall, Erik E. L. Jansen, James Killen, Xavier O'Farrell, Jane J. Kim, Karen Canfell	2021	30
6	Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia PLoS ONE ·Kate T. Simms, Michaela Hall, Megan A. Smith, Jie‐Bin Lew, Suzanne Hughes, Susan Yuill, Ian Hammond, Marion Saville, Karen Canfell	2017	27
7	High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort BMC Gastroenterology ·Jan‐Hendrik Bockmann, Marcel Grube, Vanessa Hamed, Johann von Felden, Johanna Landahl, Malte H. Wehmeyer, Katja Giersch, Michaela Hall, John M. Murray, Maura Dandri, Stefan Lüth, Ansgar W. Lohse, Marc Lütgehetmann, Julian Schulze zur Wiesch	2020	25
8	Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled Analysis Cancer Epidemiology Biomarkers & Prevention ·Megan A. Smith, Michaela Hall, Marion Saville, Julia Brotherton, Kate T. Simms, Jie‐Bin Lew, Deborah Bateson, S. Rachel Skinner, Margaret Kelaher, Karen Canfell	2020	19
9	Cost‐effectiveness analysis of silver diamine fluoride to divert dental general anaesthesia compared to standard care Australian Dental Journal ·Tan Minh Nguyen, Utsana Tonmukayakul, Michaela Hall, Hanny Calache	2022	17
10	The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study PLoS ONE ·Michaela Hall, Megan A. Smith, Kate T. Simms, Ruanne V. Barnabas, Karen Canfell, John M. Murray	2020	17
11	Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control International Journal of Cancer ·Michaela Hall, Megan A. Smith, Kate T. Simms, Ruanne V. Barnabas, John M. Murray, Karen Canfell	2021	10
12	Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand Vaccine ·Megan A. Smith, Michaela Hall, Jie‐Bin Lew, Karen Canfell	2018	8
13	A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia eLife ·Carolyn Nickson, Megan A. Smith, Eleonora Feletto, Louiza S. Velentzis, Kate Broun, Sabine Deij, Paul Grogan, Michaela Hall, Emily He, Denny John, Jie‐Bin Lew, P. Procopio, Kate T. Simms, Joachim Worthington, G. Bruce Mann, Karen Canfell	2023	6
14	The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications Gynecologic Oncology ·Michaela Hall, Megan A. Smith, Jie‐Bin Lew, Jane O’Hallahan, Gary Fentiman, Harold Neal, Margaret Sage, Karen Canfell	2019	5
15	Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010–2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening Vaccine ·Susan Yuill, Michaela Hall, Michael Caruana, Gigi Lui, Louiza S. Velentzis, Megan A. Smith, C. David Wrede, Deborah Bateson, Karen Canfell	2025	1
16	The impact of HIV on cervical cancer elimination in KwaZulu-Natal: a comparative modeling analysis JNCI Journal of the National Cancer Institute ·Christine Hathaway, Michaela Hall, Daniel D de Bondt, Cara J. Broshkevitch, Darcy W. Rao, Stefan Klein, Dorothy C. Nyemba, Danielle Travill, Sinéad Delany‐Moretlwe, Karen Canfell, Jan A. C. Hontelez, Ruanne V. Barnabas	2025	0

About Michaela Hall

Michaela Hall is a scholar working on Epidemiology, Surgery, Oncology, Microbiology and Molecular Biology, having authored 16 papers that have together received 670 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (13 papers), Genital Health and Disease (6 papers), Reproductive tract infections research (6 papers), Global Cancer Incidence and Screening (6 papers), Hepatitis B Virus Studies (3 papers), Colorectal Cancer Screening and Detection (2 papers), COVID-19 and healthcare impacts (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Epidemiology (548 citations), Microbiology (72 citations), Oncology (295 citations), Obstetrics and Gynecology (66 citations) and Health (62 citations). Michaela Hall has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include Megan A. Smith, Karen Canfell, Kate T. Simms, Jie‐Bin Lew, Marion Saville, Julia Brotherton, Ian H. Frazer, Ian Hammond, Yoon‐Jung Kang and Tracey Bessell. Their work appears in journals such as PLoS ONE, Vaccine, The Lancet Public Health, Preventive Medicine and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact